BREAST CANCER

Dec 27 2024HEALTH

Are Some Breast Cancer Patients Spared Surgery After Chemo?

You might wonder why some breast cancer patients still undergo surgery after chemotherapy. The answer involves a specific group of patients with a particular cancer stage. These patients, whose cancer is classified as ypN1 after neoadjuvant chemotherapy (NAC), are in a bit of a gray area. Doctors ar

reading time less than a minute
Dec 24 2024HEALTH

Spain's Cancer Tests: A New Perspective

In the vibrant landscape of Spain, a fresh focus is emerging around breast and gynecological cancer tests. Designed to detect individuals at risk, these tests are delivering more than just genetic insights. They’re also shedding light on the healthcare system’s responses. Talking to medical professi

reading time less than a minute
Dec 23 2024HEALTH

Improving Breast Cancer Care with JURNI: A Hospital Navigation App

Breast cancer patients face a complex health system, making timely diagnosis and treatment challenging. Digital navigation tools can help, but finding affordable solutions in Malaysia’s public sector is tough. So, researchers at the University of Malaya Medical Centre (UMMC) created JURNI, a virtual

reading time less than a minute
Dec 23 2024HEALTH

Pain After Breast Cancer: How E-Learning Can Help Professionals Collaborate

Chronic pain is a common problem for breast cancer survivors. It's important to understand that physical, psychological, and social factors all play a role in pain management. To tackle this issue effectively, healthcare professionals need to work together and use different approaches. That's why we

reading time less than a minute
Dec 23 2024HEALTH

New Hope for Advanced Breast Cancer: A Look at ADCs

Metastatic breast cancer is serious business. It's when cancer spreads from the breast to other parts of the body. There are two main types: hormone receptor-positive (HR+) and triple-negative (TN). For a long time, chemotherapy (CT) has been the standard treatment. But now, antibody-drug conjugates

reading time less than a minute
Dec 22 2024HEALTH

Which CDKI Works Best? A Real World Look at Palbociclib and Ribociclib

Imagine you're at the doctor's office, trying to figure out which medicine works best for a specific type of breast cancer. Palbociclib and ribociclib are both used to treat HR-positive, HER2-negative metastatic breast cancer, but which one is more effective? A study called OPAL (NCT03417115) tried

reading time less than a minute
Dec 21 2024HEALTH

Treating Inflammatory Breast Cancer: Challenges in Low-Income Countries

Inflammatory breast cancer (IBC) is a serious form of cancer that demands a special treatment approach called trimodal therapy (TMT). This approach includes pre-surgery medication, a modified radical mastectomy, and radiation therapy after the surgery. While this is considered the best way to treat

reading time less than a minute
Dec 21 2024HEALTH

Hormone Therapy and Breast Cancer: What Women Think

Women going through postmenopause and suffering from early-stage breast cancer often rely on hormone therapy (HT) to delay cancer's return. But HT comes with side effects that can take a toll on their overall well-being. There's a way to make it better, though. A mix of exercise and health education

reading time less than a minute
Dec 19 2024HEALTH

Breast Cancer Response to Chemo: What's Collagen Got to Do With It?

In the realm of breast cancer, the tumor's surrounding tissue, known as the stroma, plays a significant role. One key factor in this stroma is collagen fibers, which can influence the cancer's progression. A recent study delved into the connection between these collagen fibers and how well breast ca

reading time less than a minute
Dec 18 2024HEALTH

Heart Health: Breast Cancer Survivors' New Battlefield

Breast cancer survivors often grapple with a higher risk of heart disease due to the heart strain caused by cancer treatments and shared unhealthy habits. Enter the Pathways Study, which seeks to unveil how regular exercise can protect these survivors from heart issues. Isn't that intriguing? We're

reading time less than a minute